Holen Sie sich die Stockscreener-App
23.80
0.34%
-0.08
Schlusskurs vom Vortag:
$23.88
Offen:
$24.1
24-Stunden-Volumen:
1.17M
Relative Volume:
0.94
Marktkapitalisierung:
$1.77B
Einnahmen:
$97.36M
Nettoeinkommen (Verlust:
$-172.42M
KGV:
-10.36
EPS:
-2.2984
Netto-Cashflow:
$-188.84M
1W Leistung:
-3.72%
1M Leistung:
-18.77%
6M Leistung:
+91.94%
1J Leistung:
+130.40%
1-Tages-Spanne:
$23.30
$24.29
1-Wochen-Bereich:
$23.30
$25.70
52-Wochen-Spanne:
$10.38
$30.61
Xencor Inc Stock (XNCR) Company Profile
Firmenname
Xencor Inc
Sektor
Branche
Telefon
626-305-5900
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
23.80 | 1.77B | 97.36M | -172.42M | -188.84M | -2.2984 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-10-29 | Hochstufung | Barclays | Underweight → Overweight |
| 2025-09-17 | Fortgesetzt | Barclays | Underweight |
| 2025-09-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-21 | Eingeleitet | William Blair | Outperform |
| 2024-12-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Bestätigt | BTIG Research | Buy |
| 2024-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Eingeleitet | BofA Securities | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-10-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-21 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-02-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2020-02-25 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-01-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-08-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-04-12 | Eingeleitet | Guggenheim | Buy |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2019-03-15 | Eingeleitet | Raymond James | Outperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Neutral |
| 2017-03-02 | Bestätigt | Wedbush | Outperform |
| 2016-10-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-12-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-05 | Bestätigt | MLV & Co | Buy |
| 2015-02-12 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-28 | Bestätigt | MLV & Co | Buy |
| 2014-07-11 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Xencor stock falls 1.57 percent as BofA raises target - ad-hoc-news.de
Discipline and Rules-Based Execution in XNCR Response - Stock Traders Daily
Xencor, Inc. (XNCR) Stock forecasts - Yahoo Finance Singapore
Xencor, Inc. (XNCR) Stock Forecasts - finance.yahoo.com
Xencor (XNCR) Maintained by B of A Securities -- Price Target Ra - GuruFocus
Xencor (NASDAQ:XNCR) Price Target Raised to $26.00 - MarketBeat
Xencor Is Maintained at Neutral by B of A Securities - Moomoo
XENCOR, INC. : BOFA GLOBAL RESEARCH RAISES PRICE OBJECTIVE TO $26 FROM $20 - Bitget
BofA Adjusts Price Target on Xencor to $26 From $20, Keeps Neutral Rating - marketscreener.com
BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $26 - Moomoo
Xencor Inc (XE9.SG) stock price, news, quote and history - Yahoo Finance UK
Xencor stock steadies after recent earnings, analysts watch pipeline progress - ad-hoc-news.de
Xencor, Inc. (XNCR) Stock Analysis: Biotech Innovator With A 25% Upside Potential - DirectorsTalk Interviews
Xencor (XNCR) Holds Near $23.84 as Shares Consolidate Between Key LevelsATR Stop - careplusvn.com
Hsbc Holdings PLC Has $2.08 Million Position in Xencor, Inc. $XNCR - MarketBeat
Xencor (XNCR) Receives a Buy from Barclays - The Globe and Mail
Barclays Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $35 - moomoo.com
Xencor at 12th Annual Cantor Fitzgerald Global Healthcare Conference: late-stage shift - Investing.com Canada
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 260,752 Shares of Xencor, Inc. $XNCR - MarketBeat
The Manufacturers Life Insurance Company Buys Shares of 49,696 Xencor, Inc. $XNCR - MarketBeat
XNCR stock holds steady as Xencor eyes next trial milestones - ad-hoc-news.de
Seven Fleet Capital Management LP Has $5.93 Million Stake in Xencor, Inc. $XNCR - MarketBeat
Man Group plc Takes Position in Xencor, Inc. $XNCR - MarketBeat
Bank of New York Mellon Corp Makes New Investment in Xencor, Inc. $XNCR - MarketBeat
XNCR Maintained by JP Morgan -- Price Target Raised to $21.00 - GuruFocus
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Xencor (NASDAQ:XNCR) Stock - MarketBeat
Technical Reactions to XNCR Trends in Macro Strategies - Stock Traders Daily
Xencor to Present at the 2026 Cantor Global Healthcare Conference - BioSpace
Xencor (XNCR) Maintained by Raymond James -- Price Target Raised to $46 - GuruFocus
Raymond James Adjusts Xencor Price Target to $46 From $40, Maintains Strong Buy Rating - marketscreener.com
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Xencor (NASDAQ:XNCR) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Hsbc Holdings PLC Buys Shares of 125,482 Xencor, Inc. $XNCR - MarketBeat
Legal & General Group Plc Acquires Shares of 1,091,177 Xencor, Inc. $XNCR - MarketBeat
Deutsche Bank AG Acquires New Shares in Xencor, Inc. $XNCR - marketbeat.com
Bank of America Corp DE Sells 263,315 Shares of Xencor, Inc. $XNCR - marketbeat.com
BlackRock Inc. Buys Shares of 13,651,261 Xencor, Inc. $XNCR - MarketBeat
Xencor (NASDAQ:XNCR) Stock Price Down 9%What's Next? - MarketBeat
368,305 Shares in Xencor, Inc. $XNCR Bought by Seven Fleet Capital Management LP - MarketBeat
ADAR1 Capital Management LLC Invests $3.74 Million in Xencor, Inc. $XNCR - MarketBeat
Xencor (NASDAQ:XNCR) Reaches New 52-Week HighHere's Why - MarketBeat
Xencor (XNCR) Session: Rises 2.96% to $27.80 in the Latest Reading; Price Setup: the Price Remains Bounded by the Supplied Support and Resistance on the DayVolume Profile - vinanet.vn
103,736 Shares in Xencor, Inc. $XNCR Bought by DCF Advisers LLC - MarketBeat
Xencor stock hits 52-week high at 26.18 USD - Investing.com
Xencor stock hits 52-week high at 26.18 USD By Investing.com - Investing.com Canada
A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $20 to $44 - Moomoo
Xencor (NASDAQ:XNCR) Hits A Fresh High: What Comes Next? - Kalkine Media
Xencor (NASDAQ:XNCR) Sets New 52-Week HighShould You Buy? - MarketBeat
Xencor Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
Do Xencor’s (XNCR) Mixed 2026 Loss Trends Hint at Shifting Cost Discipline? - simplywall.st
Finanzdaten der Xencor Inc-Aktie (XNCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):